Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2616718012 | Eye drops suspension | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 2673152011 | Ophthalmic drops suspension | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3634765012 | Conventional release suspension for eye drops (dose form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3634766013 | Conventional release suspension for eye drops | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely dexamethasone 500 microgram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has manufactured dose form | False | Conventional release suspension for eye drops | Inferred relationship | Existential restriction modifier | |
| Product containing precisely besifloxacin 6 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has manufactured dose form | False | Conventional release suspension for eye drops | Inferred relationship | Existential restriction modifier | |
| Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release suspension for eye drops (clinical drug) | Has manufactured dose form | False | Conventional release suspension for eye drops | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR